Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP348216.RAFEIhcnNraqb_Jml2f0_ob5-00xzlc6m0M2B69dfqvgU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP348216.RAFEIhcnNraqb_Jml2f0_ob5-00xzlc6m0M2B69dfqvgU130_assertion type Assertion NP348216.RAFEIhcnNraqb_Jml2f0_ob5-00xzlc6m0M2B69dfqvgU130_head.
- NP348216.RAFEIhcnNraqb_Jml2f0_ob5-00xzlc6m0M2B69dfqvgU130_assertion wasGeneratedBy ECO_0000203 NP348216.RAFEIhcnNraqb_Jml2f0_ob5-00xzlc6m0M2B69dfqvgU130_provenance.
- NP348216.RAFEIhcnNraqb_Jml2f0_ob5-00xzlc6m0M2B69dfqvgU130_assertion wasDerivedFrom befree-2016 NP348216.RAFEIhcnNraqb_Jml2f0_ob5-00xzlc6m0M2B69dfqvgU130_provenance.
- NP348216.RAFEIhcnNraqb_Jml2f0_ob5-00xzlc6m0M2B69dfqvgU130_assertion SIO_000772 11896103 NP348216.RAFEIhcnNraqb_Jml2f0_ob5-00xzlc6m0M2B69dfqvgU130_provenance.
- NP348216.RAFEIhcnNraqb_Jml2f0_ob5-00xzlc6m0M2B69dfqvgU130_assertion evidence source_evidence_literature NP348216.RAFEIhcnNraqb_Jml2f0_ob5-00xzlc6m0M2B69dfqvgU130_provenance.
- NP348216.RAFEIhcnNraqb_Jml2f0_ob5-00xzlc6m0M2B69dfqvgU130_assertion description "[Given that high titers of hepatocyte growth factor, the specific ligand for Met, are excreted in the urine and tend to reflect disease activity of bladder cancer, we performed this study to examine the clinical significance of Met in human bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP348216.RAFEIhcnNraqb_Jml2f0_ob5-00xzlc6m0M2B69dfqvgU130_provenance.